GGrantIndex
← Leaderboards

Michael B Dwinell

Medical College Of Wisconsin

$7,415,818
Attributed
$10,344,845
Total exposure
9
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,344,845 · 9

By mechanism

R01$6,314,554 · 4
U01$2,568,769 · 1
R21$600,000 · 1
R56$329,000 · 1
R25$272,782 · 1
K01$259,740 · 1

Top collaborators

Most similar at Medical College Of Wisconsin

Same institution · by research overlap

Others in their field

Top investigators on “Signal Transduction

Research focus

Signal TransductionIn VivoCellsDesignPublishingChemokineBiochemicalMigrationTissuesTraffickingChemokine ReceptorEpithelial CellsLigandsStructureTumor GrowthPhysiologicalMalignant NeoplasmsMalignant - DescriptorExtracellularPancreatic Ductal AdenocarcinomaTumorMediatingPreventPathway Interactions

Grant awards (33)

Structure-based inhibition of chemokine signaling in the inflamed pancreas$643,818
R01 · FY2025 · DK
Mechanisms of neutrophil extracellular trap formation and contribution to biliary fibrosis in biliary atresia$545,972
R01 · FY2025 · DK
Structure-based inhibition of chemokine signaling in the inflamed pancreas$617,998
R01 · FY2024 · DK
Mechanisms of neutrophil extracellular trap formation and contribution to biliary fibrosis in biliary atresia$545,972
R01 · FY2024 · DK
Structure-based inhibition of chemokine signaling in the inflamed pancreas$662,744
R01 · FY2023 · DK
Biased chemokine receptor signaling in cancer progression$383,766
R01 · FY2023 · CA · contact PI
Biased chemokine receptor signaling in cancer progression$383,920
R01 · FY2022 · CA · contact PI
Biased chemokine receptor signaling in cancer progression$392,318
R01 · FY2021 · CA · contact PI
Biased chemokine receptor signaling in cancer progression$390,452
R01 · FY2020 · CA · contact PI
Biased chemokine receptor signaling in cancer progression$390,393
R01 · FY2019 · CA · contact PI
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$497,688
U01 · FY2018 · CA · contact PI
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$515,751
U01 · FY2017 · CA · contact PI
NIDDK Research Education Program$54,253
R25 · FY2017 · DK
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$506,653
U01 · FY2016 · CA · contact PI
NIDDK Research Education Program$54,253
R25 · FY2016 · DK
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$522,511
U01 · FY2015 · CA · contact PI
NIDDK Research Education Program$54,512
R25 · FY2015 · DK
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis$526,166
U01 · FY2014 · CA · contact PI
NIDDK Research Education Program$54,764
R25 · FY2014 · DK
NIDDK Research Education Program$55,000
R25 · FY2013 · DK
Epithelial CXCR4 in a Mucosal Communication Network$329,000
R56 · FY2010 · DK · contact PI
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK$264,660
R01 · FY2009 · DK · contact PI
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK$13,484
R01 · FY2009 · DK · contact PI
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK$264,660
R01 · FY2008 · DK · contact PI
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK$251,450
R01 · FY2007 · DK · contact PI
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK$278,127
R01 · FY2006 · DK · contact PI
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK$284,820
R01 · FY2005 · DK
Chemokines in host defense to Campylobacter jejuni$300,000
R21 · FY2004 · AI
Chemokines in host defense to Campylobacter jejuni$300,000
R21 · FY2003 · AI
CHEMOKINE RECEPTOR EXPRESSION ON INTESTINAL EPITHELIUM$90,180
K01 · FY2002 · DK
CHEMOKINE RECEPTOR EXPRESSION ON INTESTINAL EPITHELIUM$84,780
K01 · FY2001 · DK
CHEMOKINE RECEPTOR EXPRESSION ON INTESTINAL EPITHELIUM$50,719
K01 · FY2000 · DK
CHEMOKINE RECEPTOR EXPRESSION ON INTESTINAL EPITHELIUM$34,061
K01 · FY2000 · DK